The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Oral Anticoagulants and Intracranial Hemorrhage: Facts and Hypotheses
Abstract
Background Intracranial hemorrhage is the most feared and lethal complication of oral anticoagulation. We review the frequency, predictors, and prognosis of this most common neurological complication of oral anticoagulation. Summary of Review Anticoagulation to conventional intensities increases the risk of intracranial hemorrhage 7- to 10-fold, to an absolute rate of nearly 1%/y for many stroke-prone patients. Most (70%) anticoagulant-related intracranial hemorrhages are intracerebral hematomas (approximately 60% are fatal); the bulk of the remainder are subdural hematomas. Predictors of anticoagulant-related intracerebral hematoma are advanced patient age, prior ischemic stroke, hypertension, and intensity of anticoagulation. In approximately half of anticoagulated patients with intracerebral hematoma the bleeding evolves slowly over 12 to 24 hours, and emergency reversal of anticoagulation is crucial. Conclusions Both patient factors and anticoagulation intensity importantly influence the rate of anticoagulation-related intracranial hemorrhage. Patient-related risk factors for this complication overlap with those for ischemic stroke. The risk/benefit equation of anticoagulation for elderly, stroke-prone patients is complex and differs from that for younger patients. The absolute rate reduction (not the relative risk reduction) of ischemic stroke by anticoagulation is the critical issue and must offset accentuation of often lethal brain hemorrhage.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1994) · Archives of Internal Medicine · doi:10.1001/archinte.1994.00420130036007 · Cited by 2,071
EAFT (European Atrial Fibrillation Trial) Study Group (1993) · The Lancet · doi:10.1016/0140-6736(93)92358-z · Cited by 1,741
An Assessment of Clinically Useful Measures of the Consequences of Treatment
Laupacis, A., Sackett, D. L., & Roberts, R. S. (1988) · New England Journal of Medicine · doi:10.1056/nejm198806303182605 · Cited by 1,681
Risk Factors for Intracranial Hemorrhage in Outpatients Taking Warfarin
Hylek, E. M., & Singer, D. E. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-120-11-199406010-00001 · Cited by 919
Anticoagulant-related bleeding: Clinical epidemiology, prediction, and prevention
Landefeld, C. S., & Beyth, R. J. (1993) · The American Journal of Medicine · doi:10.1016/0002-9343(93)90285-w · Cited by 893
Landefeld, C. S., & Goldman, L. (1989) · The American Journal of Medicine · doi:10.1016/0002-9343(89)90564-0 · Cited by 778
Different Intensities of Oral Anticoagulant Therapy in the Treatment of Proximal-Vein Thrombosis
Hull, R., Hirsh, J., Jay, R., Carter, C., England, C., Gent, M., Turpie, A. G. G., McLoughlin, D., Dodd, P., Thomas, M., et al. (1982) · New England Journal of Medicine · doi:10.1056/nejm198212303072704 · Cited by 728
Risk Factors for Complications of Chronic Anticoagulation: A Multicenter Study
Fihn, S. D., McDonell, M., Martin, D., Henikoff, J., Vermes, D., Kent, D., White, R. H., & for the Warfarin Optimized Outpatient Follow-up Study Group* (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-118-7-199304010-00005 · Cited by 671
The Effect of Warfarin on Mortality and Reinfarction after Myocardial Infarction
Smith, P., Arnesen, H., & Holme, I. (1990) · New England Journal of Medicine · doi:10.1056/nejm199007193230302 · Cited by 638
A Comparison of Aspirin with Placebo in Patients Treated with Warfarin after Heart-Valve Replacement
Turpie, A., Gent, M., Laupacis, A., Latour, Y., Gunstensen, J., Basile, F., Klimek, M., & Hirsh, J. (1993) · New England Journal of Medicine · doi:10.1056/nejm199308193290802 · Cited by 547
Bleeding complications in oral anticoagulant therapy. An analysis of risk factors
van der Meer, F. J. (1993) · Archives of Internal Medicine · doi:10.1001/archinte.153.13.1557 · Cited by 538
Manolio, T. A., Kronmal, R. A., Burke, G. L., Poirier, V, O'Leary, D. H., Gardin, J. M., Fried, L. P., Steinberg, E. P., & Bryan, R. N. (1994) · Stroke · doi:10.1161/01.str.25.2.318 · Cited by 458
Bleeding Complications in Oral Anticoagulant Therapy: An Analysis of Risk Factors
van der Meer, F. J. M. (1993) · Archives of Internal Medicine · doi:10.1001/archinte.1993.00410130073007 · Cited by 433
Trial of Different Intensities of Anticoagulation in Patients with Prosthetic Heart Valves
Saour, J. N., Sieck, J. O., Mamo, L. A. R., & Gallus, A. S. (1990) · New England Journal of Medicine · doi:10.1056/nejm199002153220703 · Cited by 368
Turpie, A. G. G., Hirsh, J., Gunstensen, J., Nelson, H., & Gent, M. (1988) · The Lancet · doi:10.1016/s0140-6736(88)92070-3 · Cited by 315
Chesebro, J. H., Fuster, V., Elveback, L. R., McGoon, D. C., Pluth, J. R., Puga, F. J., Wallace, R. B., Danielson, G. K., Orszulak, T. A., Piehler, J. M., et al. (1983) · The American Journal of Cardiology · doi:10.1016/0002-9149(83)90673-2 · Cited by 300
Emergency reversal of anticoagulation after intracerebral hemorrhage.
Fredriksson, K., Norrving, B., & Strömblad, L. G. (1992) · Stroke · doi:10.1161/01.str.23.7.972 · Cited by 297
Neurologic deterioration in noncomatose patients with supratentorial intracerebral hemorrhage
Mayer, S. A., Sacco, R. L., Shi, T., & Mohr, J. P. (1994) · Neurology · doi:10.1212/wnl.44.8.1379 · Cited by 259
ANENCEPHALY IN THE NETHERLANDS: A REMARKABLE DECLINE
ROMIJN, J. (1983) · The Lancet · doi:10.1016/s0140-6736(83)91592-1 · Cited by 237
Contrast sonography for detection of vesicoureteral reflux
Kaneko, K., Kuwatsuru, R., Fukuda, Y., Yamataka, A., Yabuta, K., Katayama, H., & Miyano, T. (1994) · The Lancet · doi:10.1016/s0140-6736(94)92123-7 · Cited by 222
The risk of intracerebral hemorrhage during oral anticoagulant treatment: A population study
Wintzen, A. R., de Jonge, H., Loeliger, E. A., & Bots, G. T. A. M. (1984) · Annals of Neurology · doi:10.1002/ana.410160505 · Cited by 214
Anticoagulant‐related intracerebral hemorrhage
Kase, C. S., Robinson, R. K., Stein, R. W., DeWitt, L. D., Hier, D. B., Harp, D. L., Williams, J. P., Caplan, L. R., & Mohr, J. P. (1985) · Neurology · doi:10.1212/wnl.35.7.943 · Cited by 207
Intracerebral hematomas during anticoagulant treatment.
Franke, C. L., de Jonge, J., van Swieten, J. C., Op de Coul, A. A., & van Gijn, J. (1990) · Stroke · doi:10.1161/01.str.21.5.726 · Cited by 201
CYCLOPHOSPHAMIDE AND SUPPRESSOR CELL FUNCTION
Kallenberg, C. G. M. (1981) · The Lancet · doi:10.1016/s0140-6736(81)91883-3 · Cited by 191
Risk factors for complications of chronic anticoagulation
Patton, P. J. (1994) · The Journal of Emergency Medicine · doi:10.1016/0736-4679(94)90043-4 · Cited by 189
The occurrence and significance of intracerebral micro‐aneurysms
Cole, F. M., & Yates, P. O. (1967) · The Journal of Pathology and Bacteriology · doi:10.1002/path.1700930202 · Cited by 182
Aspirin and prophylaxis of thromboembolic complications in patients with substitute heart valves
Altman, R., Boullon, F., Rouvier, J., Raca, R., la Fuente, L. D., & Favaloro, R. (1976) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/s0022-5223(19)40105-0 · Cited by 172
Rådberg, J. A., Olsson, J. E., & Rådberg, C. T. (1991) · Stroke · doi:10.1161/01.str.22.5.571 · Cited by 172
LAUNBJERG, J., EGEBLAD, H., HEAF, J., NIELSEN, N. H., FUGLEHOLM, A. M., & LADEFOGED, K. (1991) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1991.tb00358.x · Cited by 169
Age-Related Risks of Long-term Oral Anticoagulant Therapy
Gurwitz, J. H. (1988) · Archives of Internal Medicine · doi:10.1001/archinte.1988.00380080037012 · Cited by 149
The E.P.S.I.M. Research Group (1982) · New England Journal of Medicine · doi:10.1056/nejm198209163071201 · Cited by 141
Olsson, J. E., Brechter, C., Bäcklund, H., Krook, H., Müller, R., Nitelius, E., Olsson, O., & Tornberg, A. (1980) · Stroke · doi:10.1161/01.str.11.1.4 · Cited by 106
Anticoagulant treatment as a risk factor for primary intracerebral haemorrhage.
Fogelholm, R., Eskola, K., Kiminkinen, T., & Kunnamo, I. (1992) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.55.12.1121 · Cited by 82
Stroke Prevention in Atrial Fibrillation II Study.
Connolly, S. (1994) · PubMed · Cited by 69
Lundström, T., & Rydén, L. (1989) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1989.tb00053.x · Cited by 63
Garde, A. H., Samuelsson, K., Fahlgren, H., Hedberg, E., Hjerne, L. G., & Östman, J. (1983) · Stroke · doi:10.1161/01.str.14.5.677 · Cited by 59
Miliary aneurysms and “Fibrinoid” degeneration of cerebral blood vessels
Rosenblum, W. I. (1977) · Human Pathology · doi:10.1016/s0046-8177(77)80076-2 · Cited by 57
Dawson, I., van Bockel, J. H., Ferrari, M. D., van der Meer, F. J., Brand, R., & Terpstra, J. L. (1993) · Stroke · doi:10.1161/01.str.24.11.1655 · Cited by 31
Goodman, S. G., Langer, A., Durica, S. S., Raskob, G. E., Comp, P. C., Gray, R. J., Hall, J. H., Kelley, R. P., Hua, T. A., Lee, R. J., et al. (1994) · The American Journal of Cardiology · doi:10.1016/0002-9149(94)90305-0 · Cited by 23
Ramadan, N. M. (1993) · Stroke · doi:10.1161/str.24.1.138a · Cited by 3
Cited by
Comparison of Warfarin and Aspirin for Symptomatic Intracranial Arterial Stenosis
Chimowitz, M. I., Lynn, M. J., Howlett-Smith, H., Stern, B. J., Hertzberg, V. S., Frankel, M. R., Levine, S. R., Chaturvedi, S., Kasner, S. E., Benesch, C. G., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043033 · Cited by 1,744
Broderick, J., Connolly, S., Feldmann, E., Hanley, D., Kase, C., Krieger, D., Mayberg, M., Morgenstern, L., Ogilvy, C. S., Vespa, P., et al. (2007) · Stroke · doi:10.1161/strokeaha.107.183689 · Cited by 1,125
Warfarin, hematoma expansion, and outcome of intracerebral hemorrhage
Flibotte, J. J., Hagan, N., O’Donnell, J., Greenberg, S. M., & Rosand, J. (2004) · Neurology · doi:10.1212/01.wnl.0000138428.40673.83 · Cited by 632
Antithrombotic and Thrombolytic Therapy for Ischemic Stroke
Albers, G. W., Easton, J. D., Sacco, R. L., & Teal, P. (1998) · Chest · doi:10.1378/chest.114.5_supplement.683s · Cited by 617
Metadata
- Authors
- Hart, R. G., Boop, B. S., & Anderson, D. C.
- Venue
- Stroke
- Published
- 1995-08
- Volume
- 26
- Issue
- 8
- Pages
- 1471-1477
- ISSN
- 0039-2499 (ISSN-L)
- 1524-4628
- OpenAlex
- W2031990245
- Cited by
- 541
- References
- 40
- FWCI
- 5.51
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.